$Abeona Therapeutics (ABEO.US)$ Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type a Meeting With FDA to Align on Upcoming Pz-Cel Bla Resubmission Abeona Therapeutics Q2 Income From Operations USD -17.864 Million Vs. IBES Estimate USD -14.6 Million Abeona Therapeutics 2Q Loss/Shr 26c Abeona Therapeutics 2Q Net $7.41M Abeona Therapeutics Q2 Cash & Investments USD 123 Million
Abeona Therapeutics股票讨论
只是
abeona therapeutics®宣布Pz-Cel获得有利的医疗保险报销决定
Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type a Meeting With FDA to Align on Upcoming Pz-Cel Bla Resubmission
Abeona Therapeutics Q2 Income From Operations USD -17.864 Million Vs. IBES Estimate USD -14.6 Million
Abeona Therapeutics 2Q Loss/Shr 26c
Abeona Therapeutics 2Q Net $7.41M
Abeona Therapeutics Q2 Cash & Investments USD 123 Million
abeona therapeutics: 当Beacon行使许可Aav204的选择时,将获得预付款,并在实现里程碑时获得额外支付
资讯
abeona therapeutics宣布定价7500万美元的普通股和预先担保认股权发行
abeona therapeutics公司宣布对普通股和预先担保认股权进行承销发行,预计将获得约7500万美元的总收入。该发行包括新老投资者,资金用于重新提交BLA、商品候选pz-cel的商业化,
🗓️ 上周的 PDUFAs:
$辉瑞 (PFE.US)$ : 已于4月26日批准 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ 血友病B
▹ 生物制品许可申请
▹ PDUFA日期:2024年第二季度
$Day One Biopharmaceuticals (DAWN.US)$ : 已批准 4/23 🎉
⇨ OJEMDA(替伏伊尼替尼)
▹ 儿童低级别胶质瘤
▹ 新药申请
▹ PDUFA日期:2024年4月30日
$ImmunityBio (IBRX.US)$ : 已批准 4/22 🎉
⇨ Anktiva + BCG
▹ 膀胱癌
▹ 重新提交BLA
▹ PDUFA日期:4/23/24
$Abeona Therapeutics (ABEO.US)$ : CRL 4/22 🙁
⚠...
暂无评论